跳到正文
cccskills
免费在 GitHub 公开

endo-cgm-confirmatory-pocbg-high-risk-hypoglycemia

Recommends real-time CGM with confirmatory bedside POC-BG monitoring for insulin dosing adjustments rather than POC-BG testing alone in adults with insulin-treated diabetes at high risk of hypoglycemia. Consider this approach for patients aged ≥65 years, BMI ≤27 kg/m², total daily insulin dose ≥0.6 units/kg, CKD stage ≥3, or recent hypoglycemia.

中文简介正在准备中。当前显示原文说明。

实测评分 未实测

查看安装方法

包含的文件(1)

  • SKILL.md2.6 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Use CGM with confirmatory POC-BG monitoring for insulin adjustments in high-risk hypoglycemia patients

STEP 1 — Gather Information

Collect age, BMI, total daily insulin dose (units/kg), CKD stage (eGFR), recent hypoglycemia history, and confirm insulin-treated diabetes with noncritical illness hospitalization.

STEP 2 — Rule In / Rule Out

If any of the following are present: age ≥65 years, BMI ≤27 kg/m², total daily insulin dose ≥0.6 units/kg, CKD stage ≥3 (eGFR <60 mL/min/1.73m²), or documented recent hypoglycemia → classify as high risk; otherwise, classify as not high risk.

STEP 3 — Classify or Stratify

If high risk, evaluate hospital availability of CGM devices, training, and protocols; if resources/training are available → select CGM with confirmatory POC-BG monitoring; if not available → select POC-BG testing alone.

STEP 4 — Decide

Implement the selected monitoring strategy to guide insulin dosing adjustments; document glucose trends and adjust insulin accordingly.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on CGM without confirmatory POC-BG for insulin dosing; avoid CGM in patients with extensive skin infections, hypoperfusion, hypovolemia, or receiving vasoactive/pressor therapy; beware of medications causing CGM interference (acetaminophen >4 g/day, dopamine, vitamin C, hydroxyurea); ensure CGM resources and training are available before deployment.

Concrete Clinical Example

A 70-year-old woman with type 2 diabetes on basal-bolus insulin admitted for pneumonia (noncritical illness) has age 70, BMI 24, TDD 0.8 units/kg, CKD stage 3b; hospital has CGM resources. Real-time CGM with confirmatory POC-BG is initiated; a trend down triggers a confirmatory POC-BG of 68 mg/dL, leading to basal insulin hold and carbohydrate intake, preventing severe hypoglycemia.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

TODO: consider adding scripts/calc.py for the endo-cgm-confirmatory-pocbg-high-risk-hypoglycemia calculator

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题